![Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1554213706/Pumalounging.jpg/Pumalounging.jpg?VersionId=AXzRJpBb66kBzE1ipO.16_8WJAXmXjo2)
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
![Puma Biotechnology: Waiting For Commercial Numbers To Catch Up To Clinical Data (NASDAQ:PBYI) | Seeking Alpha Puma Biotechnology: Waiting For Commercial Numbers To Catch Up To Clinical Data (NASDAQ:PBYI) | Seeking Alpha](https://static.seekingalpha.com/uploads/2020/12/28/48523746-16091324871455452.jpg)
Puma Biotechnology: Waiting For Commercial Numbers To Catch Up To Clinical Data (NASDAQ:PBYI) | Seeking Alpha
![anti-PUMA, Polyclonal, Novus Biologicals 0.1mg; Unlabeled:Antibodies, Polyclonal | Fisher Scientific anti-PUMA, Polyclonal, Novus Biologicals 0.1mg; Unlabeled:Antibodies, Polyclonal | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/CCG/Novus-Biologicals/product-images/PUMA-Antibody-Immunohistochemistry-Paraffin-NBP1-76639-img0009.jpg-650.jpg)
anti-PUMA, Polyclonal, Novus Biologicals 0.1mg; Unlabeled:Antibodies, Polyclonal | Fisher Scientific
![anti-PUMA, Polyclonal, Novus Biologicals 0.1mg; Unlabeled:Antibodies, Polyclonal | Fisher Scientific anti-PUMA, Polyclonal, Novus Biologicals 0.1mg; Unlabeled:Antibodies, Polyclonal | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/CCG/product-images/F788849.jpg-650.jpg)